Profile:
Cambridge Healthtech Associates™ (CHA™) uses its collaborative model to improve the speed, economics and effectiveness of life science R&D, leveraging its consulting, technology evaluations and communities to help clients in the industry penetrate the marketplace and increase revenue. CHA also manages the Drug Safety Executive Council™ (DSEC™), an online community focused on the development of better and safer medicines. Learn more at www.chacorporate.com and www.drugsafetycouncil.org.